623 related articles for article (PubMed ID: 29557230)
1. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
2. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J
Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479
[TBL] [Abstract][Full Text] [Related]
3. Vaginal compared with intramuscular progestogen for preventing preterm birth in high-risk pregnant women (VICTORIA study): a multicentre, open-label randomised trial and meta-analysis.
Choi SJ; Kwak DW; Kil K; Kim SC; Kwon JY; Kim YH; Na S; Bae JG; Cha HH; Shim JY; Oh KY; Lee KA; Kim SM; Cho IA; Lee SM; Cho GJ; Jo YS; Choi GY; Choi SK; Hur SE; Hwang HS; Kim YJ;
BJOG; 2020 Dec; 127(13):1646-1654. PubMed ID: 32536019
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth.
Elimian A; Smith K; Williams M; Knudtson E; Goodman JR; Escobedo MB
Int J Gynaecol Obstet; 2016 Aug; 134(2):169-72. PubMed ID: 27168167
[TBL] [Abstract][Full Text] [Related]
5. The association of different progesterone preparations with preterm birth prevention.
Krispin E; Hadar E; Chen R; Wiznitzer A; Kaplan B
J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3452-3457. PubMed ID: 29699436
[No Abstract] [Full Text] [Related]
6. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
[TBL] [Abstract][Full Text] [Related]
7. Preventing recurrent preterm birth with 125 mg of 17-alpha-hydroxyprogesterone caproate.
Fukuda T; Kyozuka H; Murata T; Yasuda S; Yamaguchi A; Fujimori K
J Obstet Gynaecol Res; 2021 Sep; 47(9):3119-3126. PubMed ID: 34219326
[TBL] [Abstract][Full Text] [Related]
8. Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth?
Sinkey RG; Garcia MR; Odibo AO
J Matern Fetal Neonatal Med; 2018 Jan; 31(2):202-208. PubMed ID: 28068860
[TBL] [Abstract][Full Text] [Related]
9. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
[TBL] [Abstract][Full Text] [Related]
10. Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone.
Maher MA; Abdelaziz A; Ellaithy M; Bazeed MF
Acta Obstet Gynecol Scand; 2013 Feb; 92(2):215-22. PubMed ID: 23016508
[TBL] [Abstract][Full Text] [Related]
11. Effect of partial compliance on the prevention of recurrent preterm birth in women receiving weekly 17 alpha-hydroxyprogesterone caproate injections.
Haidar ZA; Moussa HN; Hosseini Nasab S; Sibai BM
J Matern Fetal Neonatal Med; 2017 Dec; 30(24):2926-2932. PubMed ID: 27921517
[TBL] [Abstract][Full Text] [Related]
12. [Progesterone for Prevention of Preterm Birth--Evidence-based Indications].
Kuon RJ; Abele H; Berger R; Garnier Y; Maul H; Schleußner E; Rath W;
Z Geburtshilfe Neonatol; 2015 Jun; 219(3):125-35. PubMed ID: 26114408
[TBL] [Abstract][Full Text] [Related]
13. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis.
Boelig RC; Locci M; Saccone G; Gragnano E; Berghella V
Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100658. PubMed ID: 35562009
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
EPPPIC Group
Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery.
Oler E; Eke AC; Hesson A
Int J Gynaecol Obstet; 2017 Jul; 138(1):12-16. PubMed ID: 28369874
[TBL] [Abstract][Full Text] [Related]
16. Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.
Ning A; Vladutiu CJ; Dotters-Katz SK; Goodnight WH; Manuck TA
Am J Obstet Gynecol; 2017 Sep; 217(3):371.e1-371.e7. PubMed ID: 28526452
[TBL] [Abstract][Full Text] [Related]
17. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
[TBL] [Abstract][Full Text] [Related]
18. Routine second trimester cervical length screening in low risk women identified women at risk of a 'very' preterm birth but did not reduce the preterm birth rate: a randomised study from India.
Mishra S; Bagga R; Kalra J; Jain V; Dutta S
J Obstet Gynaecol; 2018 Aug; 38(6):789-795. PubMed ID: 29537316
[TBL] [Abstract][Full Text] [Related]
19. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
O'Brien JM; Lewis DF
Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
[TBL] [Abstract][Full Text] [Related]
20. Matched sample comparison of intramuscular versus vaginal micronized progesterone for prevention of preterm birth.
El-Gharib MN; El-Hawary TM
J Matern Fetal Neonatal Med; 2013 May; 26(7):716-9. PubMed ID: 23205864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
